THERAVASC INC has a total of 24 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2010. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, materials and metallurgy and foods and drinks are VELACOR THERAPEUTICS PTY LTD, STEMGEN S P A and MUNNICH ARNOLD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 2 | |
#4 | China | 2 | |
#5 | Japan | 2 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Hong Kong | 1 | |
#10 | Israel | 1 | |
#11 | India | 1 | |
#12 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Materials and metallurgy | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Non-metallic elements | |
#4 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Kevil Christopher | 20 |
#2 | Chan Kyle | 11 |
#3 | Soin Amol | 11 |
#4 | Giordano Anthony | 11 |
#5 | Flanagan Douglas R | 4 |
#6 | Constantinides Panayiotis P | 4 |
#7 | Christopher Kevil | 3 |
#8 | Anthony Giordano | 2 |
#9 | Douglas R Flanagan | 2 |
#10 | Panayiotis P Constantinides | 2 |
Publication | Filing date | Title |
---|---|---|
KR20150120479A | Pharmaceutical formulations of nitrite and uses thereof | |
US2013209584A1 | Pharmaceutical formulations of nitrite and uses thereof | |
WO2012142413A2 | Nitrite compositions and uses thereof | |
EP2488035A1 | Pharmaceutical formulations of nitrite and uses thereof | |
WO2010147742A2 | Use of nitrite salts in treating tissue damage |